The pathophysiology of PASC is described right from the initiation of the novel SARS-CoV-2 infection by primordial hijacking of host cellular metabolic machinery, subsequent progression of virus-induced human metabolic reprogramming/dysregulation (HMRD) in a susceptible host, subjecting the patient through a crucial tri-phasic symptomatic clinical onset of COVID-19 (lasting from 34 weeks), and ultimate transition of a survivor into PASC or long-COVID, a virus-free state, lingering with earlier and/or new onset disease manifestations resulting from pre-acquired HMRD (lasting for weeks to months)
H&E staining and immunohistochemistry analysis The tumor tissues fixed in 4% paraformaldehyde solution were paraffinized and sectioned (5 mm thick)
[24]Furthermore, a study by Medved et al
Would acute/short-term interventions have long-term effects
11.2 Inhibitors of phagocyte RS production Phagocytes (such as neutrophils and macrophages) have an important role as the first line of defense of an organism against pathogens
An alternate pathway exists wherein resident macrophages initially clear small urate microaggregates (UMAs) formed due to HUA
